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Abstract 
 
Background 
Vibrio infection (vibriosis) results from consuming contaminated seafood or exposing 
skin directly to marine waters or raw seafood.  The Centers for Disease Control and Prevention 
(CDC) estimates that 80,000 illnesses occur each year in the United States. Four species, V. 
parahaemolyticus, V. vulnificus, V. alginolyticus, and V. cholerae (excluding toxigenic O1 and 
O139), are responsible for most cases. Understanding foodborne and non-foodborne transmission 
routes is important for describing epidemiological trends and for directing prevention efforts.  
 
Methods 
Demographic, clinical, and epidemiological data for cases reported between 1988 and 
2012 were extracted from CDC’s Cholera and Other Vibrio Illness Surveillance System 
(COVIS). Outcomes and seasonal trends were described by species and transmission route.  
 
Results 
A total of 10,173 domestically acquired, non-toxigenic cases of vibriosis were reported, 
including 4,224 (41.5%) V. parahaemolyticus cases, 1,998 (19.6%) V. vulnificus cases, 1,267 
(12.5%) V. alginolyticus cases, and 963 (9.5%) V. cholerae cases.  There were 4,026 
hospitalizations and 795 deaths reported.  When categorized by transmission route, 5,775 
(56.8%) cases were foodborne and 3,317 (32.6%) were non-foodborne.. Most (52.4%) cases 
occurred during the summer months with peaks in July and August. Only 140 cases were 
reported from eight states in 1988 compared to 907 cases reported by 42 states in 2012. The 
overall crude incidence in 2011 was 0.26 cases per 100,000 population.  
 
Discussion 
The number of reported cases of vibriosis has been increasing steadily since 1988. 
Increased prevention efforts, including safer seafood products and consumer education, are 
needed. These efforts should focus on specific populations and transmission routes for each of 
the top four species that cause most vibriosis cases in the United States.  
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CHAPTER I 
INTRODUCTION 
1.1 Background 
Members of the family Vibrionacae, Vibrio spp.  are gram-negative, rod shaped 
bacteria that occur naturally in marine and estuarine environments (1). Generally, vibrios can 
be found living in a variety of seafood and concentrated in filter-feeding shellfish, such as 
oysters and clams (2).  Numbers of bacteria are highest during the summer months when 
waters are warmest (1, 2). Humans become exposed to vibrios via seafood consumption, 
exposure of skin to marine or estuarine waters, and exposure of the skin to raw seafood or 
drippings from raw seafood (3).With the exception of V. cholerae and V. mimicus all other 
species are halophilic, requiring salt water to survive.   The species V. cholerae can also be 
present in food or water that has been contaminated from human feces.   
There are a number of Vibrio species that are pathogenic to humans and cause 
multiple types of infections. The disease cholera is defined as illness resulting from infection 
with toxigenic Vibrio species cholerae serogroup O1 or O139 (3). Cholera is an acute illness 
characterized by watery diarrhea that can lead to dehydration and death in severe cases. V. 
cholerae O1 and O139 are responsible for cholera epidemics around the world. Human 
illnesses from infection with any other pathogenic Vibrio species are known as vibriosis. The 
clinical manifestations of vibriosis include watery diarrhea, primary septicemia, and skin or 
soft tissue infections (3).  
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The Centers for Disease Control and Prevention (CDC) estimates that Vibrio species 
cause 80,000 domestically-acquired illnesses annually (4). The Cholera and Other Vibrio 
Illness Surveillance System (COVIS) and the Foodborne Diseases Active Surveillance 
Network (FoodNet) at CDC track reported cases of vibriosis in the United States. FoodNet 
active surveillance captures information in 10 geographic sites covering approximately 15% 
of the U.S. population. COVIS collects passive surveillance data for the whole country. 
Between 1996 and 2010 an increase in reported cases of vibriosis in the United States was 
observed in both COVIS and FoodNet (5).  In 2012, FoodNet reported that the rate of 
vibriosis had increased 43% compared to the years 2006-2008 (6). 
1.2 Purpose of Study  
Building upon previous research, this thesis focuses on the four species of Vibrio that 
are responsible for the largest numbers of vibriosis cases reported to COVIS. Those species 
are Vibrio parahaemolyticus, V. vulnificus, V. alginolyticus, and V. cholerae (excluding 
toxigenic O1 and O139). Surveillance data collected by COVIS from 1988 through 2012 
from all reporting sites were used for the analysis.  The epidemiology of infections with these 
species, including demographic and clinical characteristics, is described. Specimen source 
and exposure data were used to determine transmission route trends in vibriosis overall and 
within each of the four species.  Crude incidence rates were calculated to estimate the 
increase in vibriosis from 1988-2012. The goal of this analysis is to provide a better 
understanding of the majority of vibriosis cases reported in the United States. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
2.1 Microbiology 
Vibrios are a member of the family Vibrionaceae, which are made up of eight genera. 
Recently, taxonomic changes have reclassified the species V. hollisae into a new genus 
known as Grimontia. V. damselae was also reassigned to the genus Photobacterium and is 
now known as Photobacterium damselae subsp. damselae (3). 
  Fourteen species in three genera are known to cause illness in humans (7). Toxin-
producing strains of V. cholerae O1 and O139 are the serogroups responsible for cholera, an 
acute diarrheal illness that can cause epidemics (1, 7, 8). Strains of the O1 and O139 
serogroups can also be non-toxigenic.  Although V.cholerae serogroups reported as non-O1 
and non-O139 can produce an enterotoxin that is similar to the toxin that produces cholera, 
most non-O1 strains in the United States do not have this toxin gene (8). 
Most Vibrio species are halophilic, requiring salt water to survive. They freely inhabit 
marine coastal waters and estuarine environments; occasionally they have been found in 
brackish water (1). The presence of Vibrio species in water does not indicate fecal 
contamination (1, 7). Vibrio spp. are more abundant in the environment when waters are 
warmest (7). Vibriosis can occur throughout the year. However, incidence is higher between 
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April and October and peaks in the summer months; non-foodborne vibriosis has been 
known to peak in August (7, 21).  
2.2 Clinical Presentation  
Gastroenteritis is the most common presentation of Vibrio infection from 
consumption of contaminated seafood (14).  Onset of symptoms typically occurs within 
seven days of exposure. In a study of Vibrio gastroenteritis in the U.S. Gulf of Mexico 
region, 90% of patients’ onsets occurred within three days of seafood consumption (14). 
Primary symptoms of Vibrio gastroenteritis include nausea, vomiting, diarrhea, abdominal 
cramps, fever, and bloody diarrhea. Persons infected with V. parahaemolyticus are more 
likely to have gastroenteritis than persons infected with other species (14, 15).   
Vibrio spp can cause skin and soft tissue infections, ocular and ear infections, and 
septicemia (7, 16). Some symptoms of skin infections may be similar for those with 
gastroenteritis, but cellulitis and bullae also can occur. Depending on severity, these 
infections can lead to surgical debridement or amputation. Pre-existing illnesses can increase 
risk and severity of vibriosis after seafood consumption or direct skin exposures. Persons 
with liver disease, certain immunodeficiencies, and other chronic conditions are more likely 
to have septicemia after infection with V. vulnificus, and are more likely to die from infection 
than otherwise healthy persons (17, 18).  
2.3 Exposure/Risk Factors 
Seafood consumption 
Although human illness can occur after consumption of cooked or raw seafood, 
consumption of raw seafood increases the risk for vibriosis. Because Vibrios can be 
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concentrated in the tissues of filter-feeding, bi-valve mollusks like oysters, clams, and 
mussels they are frequently reported as vehicles for vibriosis (7).  In a recent study on 
vibriosis and clam consumption, V. parahaemolyticus was the most commonly isolated 
species in patients that reported only consuming clams prior to illness onset (19). Gulf coast 
oysters harbor relatively high concentrations of V. vulnificus, and can be particularly risky 
when waters are warmest during the summer months (20). Oysters are the most commonly 
reported vehicle for V. vulnificus infection, which causes the most deaths associated with 
consuming raw oysters (20). Crustaceans (shrimp, crab, lobster, and crawfish) and finfish are 
also important vehicles. 
Direct skin contact 
Direct contact with marine or estuarine water or raw seafood products or drippings 
can result in a variety of infections. Exposing an existing wound to marine or estuarine 
waters can increase risk of infection in the skin and soft tissue. V. alginolyticus primarily 
causes infections of the skin and soft tissue as well as inner ear infections. Patients with non-
foodborne infections from V. alginolyticus are younger (median age of 30 years) than 
patients with V. vulnificus (63 years) and V. parahaemolyticus (43 years) infections (21).  
The Gulf Coast and Pacific regions of the United States report the most cases of V. 
alginolyticus annually (21). 
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2.4 Surveillance 
Cases of cholera have been nationally notifiable since 1944. Surveillance for vibriosis 
other than cholera in the United States began in 1988 as a joint effort between the CDC, the 
U.S. Food and Drug Administration (FDA), and the Gulf Coast states of Florida, Georgia, 
Mississippi, Louisiana, and Texas. By the late 1990’s, most states were reporting voluntarily 
to what is now known as the Cholera and Other Vibrio Illness Surveillance System (COVIS) 
(9). In 2007, a Council of State and Territorial Epidemiologists position statement made 
vibriosis nationally notifiable.  Information on cases of vibriosis is collected on a 
standardized COVIS case report form. The type of data collected includes demographic, 
isolate, and clinical characteristics as well as exposure and seafood investigation. This 
information is used to identify commonalities between foods consumed, host, and 
environmental risk factors.  
  The Foodborne Diseases Active Surveillance Network (FoodNet), a collaboration 
between 10 state health departments and CDC, FDA, and the U.S. Department of Agriculture 
(USDA), has also been performing Vibrio surveillance in the United States since 1996 (6). 
FoodNet is an active, population-based surveillance system that collects data on laboratory-
confirmed infections with a variety of pathogens commonly transmitted by food. The 
geographic network of state health departments captures about 15% of the U.S. population. 
Ensuring that all laboratory-confirmed cases are reported increases the completeness of 
surveillance data because it is not subject to under-reporting; however data is still subject to 
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under-diagnosis as many patients may not seek medical attention. FoodNet collects data on 
demographic, clinical characteristics, and epidemiologic information, travel, and outbreak 
status (5).  
2.5  Burden of Vibrio illness in the United States  
  In a 2011 report, CDC estimated that Vibrio causes approximately 80,000 illnesses 
in the United States each year; those illnesses result in an estimated 500 hospitalizations and 
100 deaths annually (2). The estimates relied on the concept of a “burden of illness pyramid,” 
which is a model used to represent diagnosis and reporting of foodborne illnesses. The model 
shows all persons exposed to a particular organism at the bottom of the pyramid. Some 
persons become ill, and fewer may seek medical attention. Some may then have a specimen 
collected and submitted to a laboratory, where fewer specimens may be cultured for a 
specific pathogen. When the pathogen is detected by culture, the case is considered 
laboratory-confirmed. Finally, at the top of the pyramid, some cases will be reported to a 
public health department. This model helps to understand that not all cases will be diagnosed 
or reported, and why estimated numbers of vibriosis cases are actually much larger than the 
numbers of cases reported to both COVIS and FoodNet. For example, the types of culture 
media necessary for isolating Vibrio species are specialized based on individual species. If 
appropriate media are not used, lower rates of detection and ultimately underreporting can 
result (22).  
Between 1996 and 2010, 7,700 illnesses, 2,925 hospitalizations, and 570 deaths were 
reported to COVIS (5). V. vulnificus illnesses contributed to over half of the annual deaths 
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attributed to Vibrio infection and 81% of all deaths reported to COVIS (2, 3).  Incidence of 
infection with Vibrio was highest among persons age 60 years or older; 68 % of reported 
illnesses are among males (5, 11). A relatively low overall incidence of vibriosis has been 
observed in FoodNet (0.41 per 100,000) (6). However, case fatality ratios observed by 
FoodNet are high at 5.8% (44 of 762) cases from any site of isolation and when Vibrio was 
isolated from a sterile site, such as blood, the case fatality ratio increased to 35.3% (36 of 
102) cases (10).   
Overall, V. parahaemolyticus is the most commonly reported species causing 
vibriosis in the United States. V. vulnificus is second most commonly reported species, but is 
the most commonly reported by the Gulf Coast states (5, 12).  V. vulnificus is the most deadly 
of the species contributing to 462 out of 570 deaths reported between the years of 1996-2010 
(5, 13).   V. alginolyticus, the third most commonly reported species, contributes to the 
highest number of non-foodborne infections in the United States (12). V. cholerae non-O1 
non-O139 is the fourth most commonly reported (12). Coastal states report the most cases 
annually. In 2011, only 14% of cases were reported by non-coastal states (12).   
2.6  Prevention strategies 
Understanding transmission types for vibriosis infections whether foodborne or non-
foodborne is important for directing prevention efforts. Current prevention strategies for 
vibriosis have focused heavily on education of consumers and food establishments, including 
warnings about the consumption of raw seafood on menus. For exposures to marine or 
estuarine water exposures current prevention efforts focus education and warnings to avoid 
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exposure waters when one has a wound or other underlying health conditions (13). Cooking 
shellfish correctly and avoiding cross-contamination can also reduce the risk of vibriosis 
(15). Educating persons with underlying conditions to avoid consuming raw seafood has 
been prioritized for prevention of severe infections and Vibrio-associated deaths (17). 
U.S. Food and Drug Administration (FDA) has reviewed a variety of oyster post-
harvest processing methods (23). The purpose of these methods is to reduce levels of V. 
vulnificus and V. parahaemolyticus to non-detectible levels, defined as less than 30 MPN/g. 
In 2003, California passed a law restricting the sale of Gulf Coast oysters during the period 
of April 1 through October 31 unless the oysters were proven to have been through a post-
harvest process that would reduce the amount of V. vulnificus contamination to non-
detectable levels (24). Since the law was established, California has seen a significant 
reduction in cases and deaths (24).  
 FDA published the results of the first systematic survey of post-harvest processing 
for V. vulnificus and V. parahaemolyticus in the United States in 2009. Samples were 
collected from both processors and retail, and had been treated by one of three different 
methods: high hydrostatic pressure (HHP), individual quick freezing (IQF), and mild heat 
treatment. HHP reduces microorganisms by applying high amounts of pressure (35,000 to 
40,000 psi) to shucked or half-shell oysters for a short period of time (3 to 5 minutes). The 
IQF method works by rapidly freezing oysters cryogenically and storing them frozen for an 
extended period of time. Mild heat treatment immerses whole oysters in the shell for 24 
minutes and then cools them for 15 minutes.  The report found that HHP and mild heat 
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treatment significantly reduced V. vulnificus and V. parahaemolyticus levels. IQF did not 
reduce levels of V. vulnificus to 30 MPN/g or lower (23, 25). 
Understanding foodborne and non-foodborne transmission routes is important for 
describing epidemiological trends and for directing prevention efforts. Specifically, 
describing the differences in transmission routes for the four species that cause the highest 
number of infections; will provide the greatest impact for reduction of cases. Understanding 
species-specific exposure types can also aid in prioritizing prevention measures with limited 
resource availability. Together, these data can be used to evaluate the appropriateness and 
effectiveness of prevention strategies.  
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Chapter III  
METHODOLOGY 
 
3.1 Data Sources 
For this thesis, data were extracted from the Cholera and Other Vibrio Illness 
Surveillance system (COVIS) database at CDC. State and local health officials report cases 
to COVIS using a case report form to collect data on patient demographics, specimen source 
information, clinical characteristics and exposures. If seafood is consumed, product traceback 
information is collected. Forms are submitted to CDC in electronic or paper format, and then 
entered into the COVIS database.  Table 1 summarizes the types of information collected on 
the case report form.  
Table 1: Summary of data collected through the COVIS system*  
Exposure data  Demographic 
data 
Isolate data Clinical data Seafood traceback 
Travel Age Species Symptoms Type of seafood 
Seafood 
consumption  
Sex Specimen 
source  
Hospitalization Where 
consumed/purchased 
Recreational 
water exposure 
Race/ethnicity Date of 
specimen 
collection 
Sequelae Harvest information 
 State Vibrio species 
confirmed at 
state lab 
Death Results of inspection 
 Occupation Other 
organism 
Antibiotic 
treatment 
 
   Preexisting 
conditions 
 
   Medications taken 
prior to illness 
 
*Case report form: http://www.cdc.gov/nationalsurveillance/PDFs/cdc5279-covis-vibriosis-
508c.pdf
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3.2 Transmission Route Categorization 
Exposures 
Based on exposures reported on the COVIS form, patients were classified as being 
exposed to seafood, marine or estuarine water, or both. Marine or estuarine contact includes skin 
contact with bodies of water, marine or estuarine life, and seafood drippings from raw or live 
seafood. If a patient reported more than one exposure category, such as swimming and eating 
oysters, the patient is considered to have multiple exposures; otherwise the patient is considered 
to have a single exposure to one of the categories listed above. When exposure information is not 
provided on the case report form is it considered an unknown exposure.  
Table 2. Exposure category and description 
Exposure category Exposure description 
Seafood consumption Ingestion of seafood raw or cooked in 
the 7 days before illness onset 
Marine/estuarine contact Skin contact with bodies of water or 
marine/estuarine life, or contact with 
seafood drippings in the 7 days before 
illness onset 
Unknown Exposure information not provided on 
the case report form  
 
Specimen sites 
Based on the site of specimen collection for etiologic testing and confirmation, specimen 
site data were categorized into five types: gastrointestinal, blood or other normally sterile site, 
skin or soft tissue, other/non-sterile site, and unknown site. Unknown site is chosen when a 
specimen site is not reported on the case report form. Table 3 shows examples of specimen sites 
that could be reported, but is not exhaustive of all possible sites. Similar to the exposure 
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categories, if more than one specimen site from different categories is indicated then the 
specimen site category is considered multiple. 
 
Table 3. Specimen site category and example sources 
Specimen site category Specimen source examples 
Gastrointestinal (GI) Stool, bile, appendix, rectum, gall bladder, colon 
Blood or other normally sterile site (Sterile) Blood, CSF, peritoneal fluid, lumbar disc fluid, 
lymph node, bullae 
Skin or soft tissue (SST) Wound, ear (not including otitis media and middle 
ear), appendage, tissue 
Other, non-sterile (ONS)  Urine, sputum, aspirate, bronchial washing, eye, 
otitis media, middle ear, placenta 
Unknown No specimen site reported or site not specified for 
“other” 
 
Transmission categories 
 Using the exposure and specimen site classifications previously described, cases were 
categorized into transmission routes using a hierarchy (Figure 1). Cases with a single exposure of 
seafood consumption and Vibrio isolated from a gastrointestinal (GI) site (or from multiple sites, 
but at least one was GI) were classified as a confirmed foodborne case. A probable foodborne 
case was classified when seafood consumption was reported and Vibrio was isolated only from 
skin or soft tissue (SST), other, non-sterile site (ONS) or unknown sites (or multiple sites that do 
not include GI). Conversely, cases in which Vibrio was isolated from SST, blood or other 
normally sterile site (sterile), or from multiple specimen site categories, and was only exposed to 
marine or estuarine water, were considered a confirmed non-foodborne case. A probable non-
foodborne case was classified when the specimen site is only GI, ONS, or unknown or multiple 
specimen sites that do not include SST, and exposure is only to marine or estuarine water.  
 It was possible for cases to have multiple exposures (e.g., a patient eats oysters and 
swims in the ocean). For cases with multiple exposures, it was necessary to categorize them 
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using the specimen site categories alone. A case was considered confirmed foodborne if the 
specimen site was only GI, or there were multiple specimen site categories with GI included and 
without SST. A case with multiple exposures was considered probable non-foodborne when the 
specimen site was only SST, or there were multiple specimen sites that include SST but there 
was not a site from GI. The third category for multiple exposures was unknown, which happens 
when the specimen sites are only from sterile, ONS, or an unknown site, when there are multiple 
specimen site categories, including GI and SST, or if the multiple sites do not include GI and 
SST.  Unknown or no reported exposures were classified the same as those cases with multiple 
exposures. 
3.4 Analysis 
For the purposes of this analysis, all cases reported to COVIS from 1988 through 2012 were 
used; cases that reported international travel in the 30 days prior to illness onset were excluded 
from the analysis. In addition, all toxigenic V. cholerae O1 and O139 cases were excluded from 
this analysis.  V. cholerae serogroups that were non-toxigenic were included in the analysis and 
were combined into a single category, referred to as V. cholerae. 
Basic epidemiologic information on demographics, clinical characteristics, and exposures 
were analyzed as frequencies. Chi-squared tests were used to assess the significance of observed 
differences in selected categorical data. For most questions, the case report form provides three 
options for a response: yes, no, or unknown. For hospitalizations and deaths if the question was 
answered as unknown it was coded as missing. If a question was not answered on the case report 
form it was also coded as missing. Missing data were not included in the results. Until 2007, 
Hispanic ethnicity was reported on the case report form as a category of race. The form was 
changed to separate race and ethnicity questions. To avoid double counting and maintain 
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consistency across the study period, Hispanics of all races were reported as Hispanic ethnicity 
and unknown race. 
To understand changes in reported vibriosis from 1988-2011, crude incidence rates were 
calculated for all Vibrio species and individually for V. parahaemolyticus, V. vulnificus, V. 
alginolyticus, and V. cholerae. Population data for the denominator was available through the 
year 2011; consequently, all incidence rates were calculated through the year 2011. Incidence 
rates were calculated by dividing the number of cases reported to COVIS each year by the total 
population of the reporting area for that year. A state’s population was included in the 
denominator the first year a case was reported and continuously each year subsequently. Data 
was analyzed using SAS version 9.3 (SAS Institute, Cary, NC). 
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Figure 1. Transmission categories  
 
†Probable foodborne cases are classified when a specimen is isolated from multiple specimen sites that do not include gastrointestinal. 
*Probable non-foodborne cases are classified when a specimen is isolated from multiple specimen categories not including skin or soft tissue.  
‡Unknown cases are classified when a specimen is isolated from multiple specimen site categories including gastrointestinal or skin or soft tissue, 
or neither gastrointestinal or skin or soft tissue. 
ᶳ Unknown cases are classified when a specimen is isolated from multiple specimen site categories including gastrointestinal or skin or soft tissue, 
or neither gastrointestinal or skin or soft tissue.
Specimen Site  Exposure  Transmission 
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Chapter IV  
RESULTS 
 
  
4.1 Species Results 
A total of 10,173 domestically acquired, non-toxigenic cases of vibriosis, 4,026 
hospitalizations, and 795 deaths were reported to COVIS between the years of 1988 and 
2012. The top four species contributed 8452 cases or 83.9% of all cases. V. 
parahaemolyticus contributed to the most reported cases with 4,224 (41.5%), followed by 
1,998 V. vulnificus cases (19.6%), 1,267 V. alginolyticus cases (12.5%), and 963 V. 
cholerae cases (9.5%). Initial analysis showed few demographic differences when 
comparing confirmed and probable foodborne and non-foodborne cases. Among the top 
four species there were 4414 (52.2%) confirmed foodborne cases, 276 (3.36%) probable 
foodborne cases, 2669 (31.6%) confirmed non-foodborne cases, and 214 (2.53%) 
probable non-foodborne cases.  For subsequent analyses, cases of confirmed and 
probable foodborne transmission routes were combined into one category called 
foodborne; confirmed and probable non-foodborne cases were combined into another 
category called non-foodborne. Cases with unknown transmission are presented 
separately in the results.  
Figure 2 shows the number of cases reported to COVIS annually since 1988. 
Overall, the number of cases reported increased over time. In 1988 140 cases were 
reported and in 2012 there were 907 cases reported. The number of reporting jurisdictions 
has also increased (Figure 3). In 1988, eight states reported to COVIS. In 2012, 42 states 
had reported to COVIS.  
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Figure 2. Number of cases reported to COVIS, by species, 1988-2012 
 
 
 
Figure 3. Number of jurisdictions reporting to COVIS, United States, 1988-2012 
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Demographics and clinical characteristics  
  
 Over 60% of cases of each species occurred among males (Table 4). Most 
(85.8%) V. vulnificus patients were male.  The median age varied from 32 to 58 years. V. 
alginolyticus patients had the lowest median age (32 years), while the median age of 
patients with V. vulnificus infection was 58 years. Most cases were among Whites, 
accounting for at least 65% among each of the four species.  
Table 4. Demographics by species, 1988-2012 
  V. 
parahaemolyticus 
N=4,224 
V. 
vulnificus 
N=1,998 
V. 
alginolyticus 
N=1,267 
V. cholerae 
N=963 
  n(%) n(%) n(%) n(%) 
Sex (N) 4,140 1,977 1,244 944 
  Male 
2,755 (66.6) 
1,697 
(85.8) 872 (70.1) 612 (64.8) 
Age (N) 4,076 1,959 1,212 929 
   Median(Range) 44 (1-94) 58 (0-96) 32 (0-92) 44 (0-96) 
Race/Ethnicity (N) 3,612 1,866 1,082 851 
  White 
2,554 (70.7) 
1,425 
(76.4) 752 (69.5) 558 (65.6) 
  Black or African      
American 286 (7.9) 150 (8.0) 59 (5.5) 107 (12.6) 
  Hispanic* 373 (10.3) 186 (9.9) 88 (8.1) 103 (12.1) 
  Asian 196 (5.4) 70 (3.8) 73 (6.7) 51 (6.0) 
  American Indian/Alaska   
Native 16 (0.4) 3 (0.2) 3 (0.3) 4 (0.5) 
  Native Hawaiian or  
other  Pacific Islander 8 (0.2) 3(0.2) 10 (0.9) 2 (0.2) 
  Other 17 (0.5) 5 (0.3) 7 (0.6) 3 (0.4) 
  Unknown 162 (4.5) 24 (1.3) 90 (8.3) 23 (2.7) 
*Hispanics of all races were only counted as Hispanic ethnicity.
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The most common symptoms of infection with V. parahaemolyticus were 
diarrhea (79.9%), abdominal cramps (62.9%), nausea (47.7%), and vomiting (32.2%) 
(Table 5).  Fever (61.5%) and cellulitis (55.7%) were the most common clinical 
characteristics of infection with V. vulnificus. Cellulitis was the most common clinical 
presentation in V. alginolyticus cases reported by 29.8%. V. cholerae cases reported 
diarrhea (73.6%), abdominal cramps (55.6%) and nausea (50.2%) most frequently. All 
clinical symptoms listed in Table 5, frequencies differed significantly among the top four 
species (Χ2=4690, d.f.=21,  p<0.0001). 
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Table 5.  Clinical symptoms and presentations of infection by species, 1988-2012  
 
 
  Clinical Characteristic 
  
    Fever Diarrhea 
Abdominal 
Cramps 
Nausea Vomiting 
Bloody 
Diarrhea 
Cellulitis 
Bullous 
lesions 
Species (N) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) 
V. parahaemolyticus  
(4224) 
1,148 (27.2) 3,122 (73.9) 2,657 (62.9) 2,013 (47.7) 1,358 (32.2) 501 (11.9) 447 (10.6) 75 (1.8) 
V. vulnificus  (1998) 1,229 (61.5) 557 (27.9) 493 (24.7) 717 (35.9) 595 (29.8) 94 (4.7) 1,113 (55.7) 535 (26.8) 
V. alginolyticus  (1267) 189 (14.9) 86 (6.8) 77 (6.1) 84 (6.6) 61 (4.8) 16 (1.3) 376 (29.8) 71 (5.6) 
V. cholerae  (963) 355 (36.9) 709 (73.6) 535 (55.6) 483 (50.2) 358 (37.2) 93 (9.7) 83 (8.6) 22 (2.3) 
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Outcomes 
V. parahaemolyticus was the most commonly reported species, but only 1.2% of 
cases resulted in death compared to 31.6% of cases of V. vulnificus (Table 6). 
Hospitalization was most common among V. vulnificus cases (85.0%) and V. cholerae 
cases (45.9%). Hospitalization and death were least commonly reported for V. 
alginolyticus cases at less than one percent.  
Table 6. Hospitalizations and deaths reported to COVIS, by species, 1988-2012 
  Total Cases Hospitalizations Deaths 
Species N (%)* n(%) n(%) 
V. 
parahaemolyticus 
4,224 (41.5) 949 (22.5) 46 (1.2) 
V. vulnificus 1,998 (19.6) 1,699 (85.0) 631 (31.6) 
V. alginolyticus 1,267 (12.5) 216 (17.0) 12 (<1) 
V. cholerae* 963 (9.6) 442 (45.9) 51 (5.3) 
All other species 1,721 (125) 720 (41.8) 55 (3.2) 
Total 10173 4026 795 
*Percent of total cases reported  
 
 
Specimen site and exposures 
 
 The most common site of specimen isolation for V. parahaemolyticus and V. 
cholerae cases was GI (Table 7).  Isolation from sterile  sites were most common for V. 
vulnificus cases. V. alginolyticus was isolated from SST in 82.7% of cases. Multiple 
specimen sites were common among V. vulnificus cases (11.5%). For GI, sterile, and SST 
specimen sites, frequencies differed significantly among the top 4 species (Χ2=6,438.3, 
d.f.=6,  p<0.0001).
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Table 7. Specimen site category by species, 1988-2012* 
    Specimen site category 
  
Species 
Total 
Gastrointestinal 
(GI) 
Blood or other 
normally sterile 
(Sterile) 
Skin or soft 
tissue 
(SST) 
Other, 
non-sterile 
(ONS) Unknown Multiple 
Species N n(%) n(%) n(%) n(%) n(%) n(%) 
V. parahaemolyticus 4,224 3,261 (77.2) 113 (2.3) 609 (14.4) 33 (0.8) 177 (4.2) 31 (0.7)
†
 
V. vulnificus 1,998 87 (4.4) 1,123 (56.2) 492 (24.6) 28 (1.4) 38 (1.9) 230 (11.5)
‡
 
V. alginolyticus 1,267 56 (4.4) 50 (39) 1,048 (82.7) 59 (4.7) 49 (3.8) 5 (0.4)
§
 
V. cholerae 963 566 (58.8) 171 (17.8) 108 (11.2) 58 (6.0) 37 (3.8) 23 (2.4)¶ 
*For specific specimen sources please refer to the methods section.        
†Sterile and GI (7); sterile and SST (14); sterile and ONS (1); sterile and unknown (1); GI and SST (5); GI and ONS (2); SST or other (1)      
‡ Sterile, GI and unknown (1); sterile and GI (12); sterile and SST (195); sterile and ONS (2); sterile, SST, and GI (1); sterile and unknown (3); GI and SST (5); SST and ONS (2)  
§ Sterile, GI, SST, and other (1); sterile and GI (11); sterile and SST (8); sterile and ONS (2); GI and SST (1)  
¶ Sterile and SST (2); sterile and ONS (2); SST and other (1)   
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 Seafood consumption was reported more often among V. parahaemolyticus 
(76.6%) and V. cholerae patients(60.3%) (Table 8). Marine or estuarine contact was  
reported most often V.vulnificus (60.4%) and V. algnolyticus (62.6%) patients. Many 
patients reported both seafood consumption and marine or estuarine exposure.  
 
Table 8. Exposures by species, 1988-2012 
 
Seafood Consumption Marine/Estuarine Contact* 
 
Yes No Unknown Yes No Unknown 
Species n(%) n(%) n(%) n(%) n(%) n(%) 
V. parahaemolyticus 3,067 (72.6) 407 (9.6) 750 (17.8) 1,418 (33.6) 1,926 (45.6) 880 (20.8) 
V. vulnificus 1,100 (55.1) 406 (20.3) 492 (24.6) 1,206 (60.4) 445 (22.3) 347 (17.4) 
V. alginolyticus 236 (18.6) 435 (34.3) 596 (47.0) 793 (62.6) 227 (17.9) 247 (19.5) 
V. cholerae 581 (60.3) 170 (17.7) 212 (22.0) 364 (37.8) 407 (42.3) 192 (19.9) 
*Marine/Estuarine contact includes contact with a body of water, seafood drippings, or any marine wildlife. 
 
 
4.2  Transmission Categories  
Foodborne transmission represented the largest number of cases (n=5,775, 56.8%) 
followed by non-foodborne (n=3,317, 32.6%) and unknown (n=1,081, 10.6%) (Table 9). 
Foodborne V. parahaemolyticus had the largest number of cases among all species and 
transmission categories, accounting for 33% of all reported vibriosis cases.  V. vulnificus 
cases represented the most cases in the unknown transmission category (n=514, 25.7%).  
V. alginolyticus had the highest number of non-foodborne cases (n=1,080).  For 
foodborne and non-foodborne, frequencies differed significantly among the top four 
species (Χ2=2,528.1, d.f.=3,  p<0.0001). 
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Table 9. Species by transmission category, 1988-2012 
  Foodborne Non-foodborne Unknown 
Species 
Total 
Species n(%) n(%) n(%) N 
V. parahaemolyticus 3,361 (79.6) 723 (17.1) 140 (3.3) 4,224 
V. vulnificus 596 (29.8) 888 (44.4) 514 (25.7) 1,998 
V. alginolyticus 98 (7.7) 1,080 (85.2) 89 (7.0) 1,267 
V. cholerae  635 (65.9) 194 (20.2) 134 (13.9) 963 
All other species 1,085 (63.0) 432 (25.1) 204 (11.9) 1,721 
Grand Total  5,775 (56.8) 3,317 (32.6) 1,081 (10.6) 10,173 
 
 
Demographics and clinical characteristics  
 
 Demographics varied by species and transmission (Tables 10-13). The median 
age of non-foodborne V. parahaemolyticus patients was 42 years old and over 80% were 
White. The median age for all V. vulnificus patients was higher compared to all other 
species and transmission categories; non-foodborne V. vulnificus patients have the 
highest median age of 61 years. Non-foodborne V. vulnificus also had the highest 
percentage of White patients (86.9%). Foodborne V. alginolyticus and V. cholerae had 
the highest percentage of females (38.8% and 39.2%, respectively).  Non-foodborne V. 
alginolyticus and V. cholerae had the lowest median age at 28 years for both species.  
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Table 10. Demographics of V. parahaemolyticus cases, by transmission, 1988-2012 
  
Foodborne 
N=3,361 
Non-foodborne 
N=723 
Unknown 
N=140 
  n(%) n(%) n(%) 
Sex 3,298 709 131 
Male 2,131 (64.6) 538 (75.9) 86 (65.7) 
Age 3,243 704 129 
    Median(Range) 44 (1-94) 42 (1-92) 48 (1-92) 
Race/Ethnicity* 2,868 636 108 
    White 1,966 (68.5) 515 (81.1) 72 (66.7) 
Black or African American 235 (8.2) 39 (6.1) 12 (11.1) 
Hispanic
†
 330 (11.5) 30 (4.7) 13 (12.0) 
Asian 168 (5.9) 24 (3.8) 4 (3.7) 
American Indian/Alaska Native 15 (0.5) 1 (0.2) 0 (0) 
Native Hawaiian or other Pacific 
Islander 
8 (0.3) 0 (0) 0 (0) 
Other 12 (0.4) 4 (0.6) 0 (0) 
Unknown 134 (4.7) 21 (3.3) 7 (6.5) 
* For foodborne and non-foodborne, frequencies differed significantly among Whites, Blacks/African Americans,  
Hispanics, and Asians (Χ2=41.13, d.f.=3,  p<0.0001). 
† 
Hispanics of all races were only counted as Hispanic ethnicity. 
Table 11. Demographics of V. vulnificus cases, by transmission, 1988-2012 
  
Foodborne 
N=596 
Non-foodborne 
N=888 
Unknown 
N=514 
  n(%) n(%) n(%) 
Sex 589 877 511 
Male 491 (83.4) 776 (88.5) 430 (84.2) 
Age 589 863 507 
Median(Range) 55 (0-93) 61 (1-94) 56 (0-96) 
Race/Ethnicity* 561 822 483 
White 378 (67.4) 700 (85.2) 347 (71.8) 
Black or African American 42 (7.5) 56 (6.8) 52 (10.8) 
Hispanic
†
 101 (18.0) 34 (4.1) 51 (10.6) 
Asian 31 (5.5) 16 (1.9) 23 (4.8) 
American Indian/Alaska Native 1 (0.2) 2 (0.2) 0 (0) 
Native Hawaiian or other Pacific 
Islander 
1 (0.2) 1 (0.1) 1 (0.2) 
Other 1 (0.2) 1 (0.1) 3 (0.6) 
Unknown 6 (1.1) 12 (1.5) 6 (1.2) 
* For foodborne and non-foodborne, frequencies differed significantly among Whites, Blacks/African Americans,  
Hispanics, and Asians (Χ2=91.9, d.f.=3,  p<0.0001). 
† 
Hispanics of all races were only counted as Hispanic ethnicity.
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Table 12. Demographics of V. alginolyticus cases, by transmission, 1988-2012 
  
Foodborne 
N=98 
Non-
foodborne 
N=1,080 
Unknown 
N=89 
  n(%) n(%) n(%) 
Sex 98 1,058 86 
Male 60 (61.2) 752 (71.2) 60 (69.8) 
Age 97 1,031 84 
Median(Range) 48 (0-92) 28 (0-89) 43 (0-86) 
Race/Ethnicity* 91 919 72 
White 63 (69.2) 647 (70.4) 42 (58.3) 
Black or African American 9 (9.9) 40 (4.4) 10 (13.9) 
Hispanic
†
 7 (7.7) 76 (8.3) 5 (6.9) 
Asian 7 (7.7) 64 (6.9) 2 (2.8) 
American Indian/Alaska Native 1 (1.1) 2 (0.2) 0 (0) 
Native Hawaiian or other Pacific 
Islander 
2 (2.2) 8 (0.9) 0 (0) 
Other 1 (1.1) 5 (0.5) 1 (1.4) 
Unknown 1 (1.1) 77 (8.4) 12 (16.7) 
* For foodborne and non-foodborne, frequencies did not differ significantly among Whites, Blacks/African Americans, 
Hispanics, and Asians (Χ2=4.96, d.f.=3,  p=0.1747).  
† 
Hispanics of all races were only counted as Hispanic ethnicity.
 
 
Table 13. Demographics of V. cholerae cases, by transmission, 1988-2012 
  
Foodborne 
N=635 
Non-
foodborne 
N=194 
Unknown 
N=134 
  n(%) n(%) n(%) 
N 635 194 134 
Sex 622 189 133 
Male 378 (60.8) 135 (71.4) 99 (74.4) 
Age 609 189 131 
Median(Range) 46 (0-96) 28 (0-93) 52 (0-95) 
Race/Ethnicity* 566 170 115 
White 377 (66.6) 111 (65.3) 70 (60.9) 
Black or African American 81 (14.3) 14 (8.2) 12 (10.4) 
Hispanic
†
 59 (10.4) 22 (12.9) 22 (19.1) 
Asian 32 (5.7) 11 (6.5) 8 (6.9) 
American Indian/Alaska Native 1 (0.2) 3 (1.8) 0 (0) 
Native Hawaiian or other Pacific 
Islander 
2 (0.4) 0 (0) 0 (0) 
Other 2 (0.4) 1 (0.6) 0 (0) 
Unknown 12 (2.1) 8 (4.7) 3 (2.6) 
* For foodborne and non-foodborne, frequencies did not differ significantly among Whites, Blacks/African Americans,  
Hispanics, and Asians (Χ2=4.56, d.f.=3,  p=0.207). 
† 
Hispanics of all races were only counted as Hispanic ethnicity.
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Clinical characteristics of each species varied by transmission category (Tables 
14-17). Diarrhea and abdominal cramps were most common in foodborne V. 
parahaemolyticus and foodborne V. cholerae patients. Over 70% of V. vulnificus cases in 
all transmission categories reported fever. Cellulitis was reported by more patients with 
(86.7%) non-foodborne V. vulnificus and non-foodborne V. alginolyticus (40.7%). 
Bullous lesions were reported less frequently and but were most common among non-
foodborne V. vulnificus (44.0%). 
Table 14. Clinical characteristics of V. parahaemolyticus cases, by transmission, 1988-
2012
*  
 
Foodborne Non-foodborne Unknown 
Clinical Characteristic
*
 n(%) n(%) n(%) 
    Fever 893  (33.6) 211 (37.6) 44 (52.4) 
Diarrhea 2,985 (97.0/) 92 (16.3) 45 (51.1) 
Abdominal Cramps 2,538 (84.14) 79 (14.3) 40 (45.9) 
Nausea 1,871 (63.8) 107 (18.9) 35 (41.7) 
Vomiting 1,267 (43.17) 65 (11.6) 26 (30.2) 
Bloody Diarrhea 478 (18.2) 13 (2.4) 10 (12.7) 
Cellulitis 41 (1.5) 386 (65.4) 20 (25.3) 
Bullous lesions 21 (0.8) 49 (10.2) 5 (6.9) 
* For foodborne and non-foodbornetransmission frequencies differed significantly for all clinical characteristics among V. 
parahaemolyticus cases  (Χ2=4230 d.f.=7,  p<0.0001). 
 
Table 15. Clinical characteristics of V. vulnificus cases, by transmission, 1988-2012
*  
 
Foodborne Non-foodborne Unknown 
Clinical Characteristic
*
 n(%) n(%) n(%) 
    Fever 391 (78.7) 539 (72.2) 299 (77.3) 
Diarrhea 287 (59.9) 126 (18.2) 144 (40.7) 
Abdominal Cramps 83 (12.4) 120 (36.1) 290 (61.6) 
Nausea 290 (61.6) 249 (35.1) 178 (50.0) 
Vomiting 266 (54.9) 173 (24.6) 156 (42.6) 
Bloody Diarrhea 51 (13.8) 16 (2.5) 27 (8.8) 
Cellulitis 207 (48.8) 676 (86.7) 230 (64.3) 
Bullous lesions 144 (37.4) 273 (44.0) 118 (39.7) 
* For foodborne and non-foodborne transmission frequencies differed significantly for all clinical characteristics among V. vulnificus 
cases  (Χ2=376 d.f.=7,  p<0.0001). 
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Table 16. Clinical characteristics of V. alginolyticus cases, by transmission, 1988-2012
*  
 
Foodborne Non-foodborne Unknown 
Clinical Characteristic
*
 n(%) n(%) n(%) 
    Fever 26 (31.3) 145 (17.6) 18 (39.1) 
Diarrhea 44 (53.7) 37 (4.5) 5 (11.1) 
Abdominal Cramps 35 (43.2) 36 (4.5) 6 (13.3) 
Nausea 27 (33.8) 50 (6.1) 7 (15.9) 
Vomiting 22 (27.2) 31 (3.8) 8 (18.2) 
Bloody Diarrhea 11 (14.3) 4 (0.5) 1 (2.3) 
Cellulitis 21 (28.0) 345 (40.7) 10 (22.7) 
Bullous lesions 6 (8.7) 64 (8.6) 1 (2.6) 
 * For foodborne and non-foodborne transmission frequencies differed significantly for all clinical characteristics among V. 
alginolyticus cases  (Χ2=196  d.f.=7,  p<0.0001). 
 
 
 
Table 17. Clinical characteristics of V. cholerae cases, by transmission, 1988-2012
*
 
 
Foodborne Non-foodborne Unknown 
Clinical Characteristic
*
 n(%) n(%) n(%) 
Fever 232 (44.9) 60 (42.6) 63 (64.3) 
Diarrhea 539 (90.6) 59 (38.3) 40 (42.6) 
Abdominal Cramps 428 (78.7) 53 (35.6) 54 (56.3) 
Nausea 378 (67.4) 57 (37.3) 48 (50.0) 
Vomiting 279 (49.6) 41 (26.9) 38 (41.3) 
Bloody Diarrhea 73 (14.8) 7 (4.9) 13 (15.3) 
Cellulitis 15 (3.1) 52 (35.4) 16 (18.8) 
Bullous lesions 7 (1.5) 9 (6.9) 6 (7.3) 
* For foodborne and non-foodborne transmission frequencies differed significantly for all clinical characteristics among V. cholerae  
cases  (Χ2=261 d.f.=7,  p<0.0001). 
 
Outcomes 
 Outcomes varied by species and transmission (Table 18). Nearly two-thirds 
(64.4%) of V. parahaemolyticus hospitalizations were among cases with foodborne 
transmission. Deaths from V. parahaemolyticus among patients with foodborne 
transmission were common (41.3%). V. vulnificus hospitalizations were highest among 
patients with non-foodborne transmission (42.8%); deaths were highest in foodborne 
patients (44.06%). V. alginolyticus patients had the lowest number of deaths among all 
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species and transmission categories (<1%) and the lowest number of hospitalizations 
among foodborne (11.1%) and unknown transmission (12.0%) patients.  
Table 18. Number of cases, hospitalizations, and deaths reported to COVIS by 
transmission category and species, 1988-2012 
  Foodborne Non-foodborne Unknown Total 
Species n(%) n(%) n(%) N 
V. parahaemolyticus 3,361 (79.6) 723 (17.1) 140 (3.3) 4224 
Hospitalizations 611 (64.4) 288 (30.3) 50 (5.3) 949 
Deaths 19 (41.3) 13 (28.3) 14 (30.4) 46 
V. vulnificus 596 (29.8) 888 (44.4) 514 (25.7) 1998 
Hospitalizations 527 (31.0) 727 (42.8) 445 (26.2) 1699 
Deaths 278 (44.1) 142 (22.5) 211 (33.4) 631 
V. alginolyticus 98 (7.7) 1,080 (85.2) 89 (7.0) 1267 
Hospitalizations 24 (11.1) 166 (76.9) 26 (12.0) 216 
Deaths 1 (8.3) 7 (58.3) 4 (33.3) 12 
V. cholerae 635 (65.9) 194 (20.2) 134 (13.9) 963 
Hospitalizations 279 (63.1) 75 (16.9) 88 (19.1) 442 
Deaths 18 (35.3) 10 (19.6) 23 (45.9) 51 
All other species 1085 (63.0) 432 (25.1) 204 (11.9) 1721 
Hospitalizations 443 (61.5) 186 (25.8) 91 (12.6) 720 
Deaths 20 (2.1) 13 (3.5) 22 (13.9) 55 
All Cases 
   
  
  Hospitalizations 1,884 (34.5) 1,442 (47.8) 700 (77.8) 4026 
  Deaths 336 (42.3) 185 (23.3) 274 (34.5) 795 
Total 5,775 (56.8) 3,317 (32.6) 
1,081 
(10.6) 
10173 
 
Almost 76% of foodborne V. parahaemolyticus cases were from a gastrointestinal 
specimen site, compared to 1.35% of non-foodborne V. parahaemolyticus cases (Table 
19). More than half (56.2%) of all V. vulnificus infections were isolated from blood or 
other normally sterile sites. Most (79.7%) V. alginolyticus cases were non-foodborne 
transmission from a skin or soft tissue specimen site. Gastrointestinal specimens from 
foodborne V. cholerae represented the largest specimen site category of all V. cholerae 
cases (58.78%).   
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Table 19. Specimen site categories for reported cases by species and transmission* 
  Foodborne Non-foodborne Unknown Species Total 
  n(%) n(%) n(%) N(%) 
V. parahaemolyticus 3,361 (79.6) 723 (17.1) 140 (3.3) 4,224 (100) 
Gastrointestinal (GI) 3,204 (95.3) 57 (7.9) 0 (0) 3,261 (77.2) 
Blood or other normally sterile 
(Sterile) 
38 (1.1) 32 (4.4) 43 (30.7) 113 (2.9) 
Skin or soft tissue (SST) 13 (0.4) 596 (82.4) 0 (0) 609 (14.4) 
Other, non-sterile (ONS) 8 (0.2) 9 (1.2) 16 (11.4) 33 (0.8) 
Unknown 89 (2.7) 12 (1.7) 79 (54.3) 177 (4.2) 
Multiple† 9 (0.3) 17 (2.4) 5 (3.6) 31 (0.7) 
V. vulnificus 596 (29.8) 888 (44.4) 514 (25.70 1,998 (100) 
Gastrointestinal (GI) 85 (14.3) 2 (0.2) 0 (0) 87 (4.4) 
Blood or other normally sterile 
(Sterile) 
404 (67.8) 252 (28.4) 467 (90.9) 1123 (56.2) 
Skin or soft tissue (SST) 33 (5.5) 459 (51.7) 0 (0) 492 (24.6) 
Other, non-sterile (ONS) 2 (0.3) 11 (1.2) 15 (2.9) 28 (1.4) 
Unknown 14 (2.4) 6 (0.7) 18 (3.5) 38 (1.9) 
Multiple‡ 58 (9.7) 158 (17.8) 14 (2.7) 230 (11.5) 
V. alginolyticus 98 (7.7) 1,080 (85.2) 89 (7.0) 1,267 (100) 
Gastrointestinal (GI) 49 (50.0) 7 (0.6) 0 (0) 56 (4.4) 
Blood or other normally sterile 
(Sterile) 
4 (4.1) 19 (1.8) 27 (30.3) 50 (3.9) 
Skin or soft tissue (SST) 38 (38.8) 1,010 (93.5) 0 (0) 1,048 (82.7) 
Other, non-sterile (ONS) 4 (4.1) 29 (2.7) 26 (29.2) 59 (4.7) 
Unknown 2 (2.0) 12 (1.1) 35 (39.3) 49 (3.8) 
Multiple§ 1 (1.0) 3 (0.3) 1 (1.1) 5 (0.4) 
V. cholerae  635 (65.9) 194 (20.2) 134 (13.9) 963 (100) 
Gastrointestinal (GI) 532 (83.8) 34 (17.5) 0 (0) 566 (58.8) 
Blood or other normally sterile 
(Sterile) 
64 (10.1) 18 (9.3) 89 (66.4) 171 (17.8) 
Skin or soft tissue (SST) 7 (1.1) 101 (52.1) 0 (0) 108 (11.2) 
Other, non-sterile (ONS) 8 (1.3) 29 (14.9) 21 (15.8) 58 (6.0) 
Unknown 10 (1.8) 5 (2.6) 22 (16.4) 37 (3.8) 
Multiple¶ 14 (2.2) 7 (3.6) 2 (1.5) 23 (2.4) 
All other species 1,085 (63.0) 432 (25.1) 204 (11.9) 1,721 (100) 
Gastrointestinal (GI) 959 (88.4) 22 (5.1) 0 (0) 981 (57.0) 
Blood or other normally sterile 
(Sterile) 
33 (3.0) 21 (4.9) 55 (26.9) 109 (6.3) 
Skin or soft tissue (SST) 17 (1.8) 344 (79.6) 0 (0) 361 (20.9) 
Other, non-sterile (ONS) 19 (1.8) 12 (2.8) 58 (58.4) 89 (5.2) 
Unknown 46 (4.2) 15 (3.5) 86 (42.2) 147 (8.5) 
Multiple** 11 (1.0) 18 (4.2) 5 (2.5) 34 (1.9) 
Grand Total  5,775 (56.8) 3,317 (32.6) 1,081 (10.6) 10,173 
*For specific specimen sources please refer to the methods section. 
†Sterile and GI (7); Sterile and SST (14); sterile and ONS (1); sterile and unknown (1); GI and SST(5); GI and ONS (2); SST and 
other (1) 
‡Sterile, GI and unknown (1); sterile and GI (12); sterile and SST (195); sterile and ONS (2); sterile, SST, and GI (1); sterile and 
unknown (3); GI and SST (5); SST and ONS (2) 
§Sterile, GI, SST, other (1); sterile and GI (11); sterile and SST (8); sterile and ONS (2); GI and SST (1) 
¶Sterile and SST (2); Sterile and ONS (2); SST and other (1) 
**Sterile and GI (7) 
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Geography 
 
 Coastal states reported the most cases to COVIS. California has reported 1,054 
foodborne cases since their first report in 1988 followed by Florida (544) andWashington 
(464). Among the California foodborne cases, most (91%) were V. parahaemolyticus. 
Florida reported the most non-foodborne cases (1,013) followed by Texas (406) and 
Hawaii (242). V.alginolyticus was the most commonly reported non-foodborne species 
among Florida cases (39%). Florida also had the most cases with unknown transmission 
routes (206); 67% of those cases were V.vulnificus. 
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Figure 4. Cases by month and transmission, 1988-2012 
34 
 
Seasonality 
 
 Radar plots demonstrate the seasonality of infections by species and transmission 
(Figure 4).The number of foodborne and non-foodborne cases by month and species. The 
axis for V. parahaemolyticus is greater than those for the other three species because the 
number of cases reported is higher.   The majority of cases occurred during the summer 
months among all species (52.4%). Foodborne V. parahaemolyticus cases peaked in July 
and August; non-foodborne cases peaked in July. Foodborne V. vulnificus rose sharply 
from June to peak in August and declined again sharply in September.  By comparison, 
non-foodborne V. vulnificus cases gradually increased through the spring and summer 
months to a peak in August.  Non-foodborne V. alginolyticus cases peaked in July and 
August. Foodborne V. cholerae cases were highest in the month of May but remained 
high through June and July.
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4.3 Crude Incidence Rates 
Figure 5 shows the crude incidence rate of Vibrio infections in the United States since 
surveillance began in 1988. Incidence has increased 62.5% between 1988 and 2011 from 
0.16 cases per 100,000 population to 0.26 cases per 100,000 population. Reporting rates 
of states have been most consistent since 2000, making the data more reliable from 2000 
onward. Rates for V. parahaemolyticus shown in Figure 6 have been increasing since 
1988, from 0.032 per million in 1988 to 0.098 per million in 2011. The highest rate of V. 
parahaemolyticus occurred in 2006 at 0.13 per million population. Rates have increased 
steadily for V. alginolyticus and in 2011, were 0.048 per 100,000 population. The crude 
incidence of V. cholerae has had little change over time (Figure 6).  
Figure 5. Crude incidence rate of Vibrio infections, all species, 1988-2011 
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Figure 6. Crude incidence rate by species, 1988-2011                 
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Incidence rates among foodborne and non-foodborne transmission cases have 
fluctuated over time (Figure 7). Like the rates for overall incidence and for each of the 
four species, reporting rates were most consistent beginning in the year 2000.  In 2011, 
rates of foodborne Vibrio infections were 0.13 cases per 100,000 population; non-
foodborne infections were 0.10 cases per 100,000 population.  
Figure 7. Incidence rate of foodborne and non-foodborne Vibrio infections, 1988-2011 
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Incidence rates for the top four species vary by transmission (Figures 8-11). 
Incidence rates of foodborne V. parahaemolyticus have increased since 1988. In 2011, 
the crude rate for foodborne V. parahaemolyticus was 0.075 cases per 100,000 
population. Non-foodborne cases have also increased and in 2011 the crude rate was .02 
per 100,000 population. Rates of foodborne and non-foodborne V. vulnificus infections 
have varied over time and non-foodborne rates have remained highest. In 2011, the crude 
rate for non-foodborne V. vulnificus infections was 0.017 per 100,000 population. The 
crude rate for non-foodborne V. alginolyticus cases has increased steadily since 2000 
(0.01 per 100,000) and in 2011 was 0.04 per 100,000 population. The crude rates for V. 
cholerae infections have remained stable for both foodborne and non-foodborne cases. 
However, the highest rates are among foodborne cases; in 2011 the crude rate was 0.015 
per 100,000 population.  
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Figure 8. Crude incidence rate of V. parahaemolyticus cases by transmission, 1988–
2011
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Figure 9. Crude incidence rate of V. vulnificus cases by transmission, 1988–2011 
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Figure 10. Crude incidence rate of V. alginolyticus cases by transmission, 1988–2011 
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Figure 11. Crude incidence rate of V. cholerae cases by transmission, 1988–2011 
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Chapter V  
DISCUSSION AND CONCLUSION 
 
5.1 Discussion 
Vibriosis is an important public health problem in the United States that affects an 
estimated 80,000 persons annually (4). V. parahaemolyticus, V. vulnificus, V. 
alginolyticus, and V. cholerae are the species most reported to COVIS and together 
contribute to 83.9% of the total reported cases. Between 1988 and 2012, 10,173 cases of 
these top four species and 4,026 hospitalizations and 795 deaths were reported to COVIS. 
Reporting of vibriosis has increased since 1988 when the Gulf Coast states first began 
surveillance for vibrios other than V. cholerae O1 and O139. In 1988 only 140 cases were 
reported from eight states. In 2012, 907 cases were reported from 42 states. Not only has 
the reporting population increased, incidence rates have also increased over time to 0.26 
cases per 100,000 population in 2011.   
 This analysis showed that understanding differences of foodborne and non-
foodborne transmission routes overall and among Vibrio spp. are important for 
characterizing epidemiological trends.  Both routes play significant roles in infection in 
the United States (14, 21). All of the top four species are transmitted through both 
foodborne and non-foodborne routes, though for some species the proportion of 
infections transmitted through food may be much smaller than those transmitted through 
non-foodborne exposures. For example, foodborne V. alginolyticus represents only 7.8% 
of all V. alginolyticus cases, but 85.2% of cases are non-foodborne. Differences in 
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outcomes suggest that the foodborne transmission contributes to the highest burden of 
infection and deaths, but that non-foodborne infections should be considered equally as 
important (21). Incidence rates of foodborne infections are highest among all species 
reported to COVIS. In 2011, the crude rate of foodborne cases was 0.13 per 100,000 
population. Rates of non-foodborne vibriosis were 0.10 per 100,000 population in 2011.  
V. parahaemolyticus contributed the largest number of cases in COVIS (4,224). 
Gastroenteritis was the most commonly reported result of infection in V. 
parahaemolyticus, as seen in other studies (15). However, septicemia also occurred 
among patients (14, 15). Incidence rates of both foodborne and non-foodborne V. 
parahaemolyticus cases have been increasing. However, foodborne rates remained higher 
and were 0.075 per 100,000 population in 2011. High rates of V. parahaemolyticus have 
also been observed in FoodNet and among individual states (4, 13, 29).  
Outbreaks may be a significant contributor to high rates of foodborne V. 
parahaemolyticus cases (26, 27) and may play an important role in the increase of 
vibriosis. The Foodborne Outbreak Online Database (FOOD) is a tool created for users to 
view information about outbreaks reported to the National Outbreak Reporting System 
(NORS) at CDC. The database shows that a number of outbreaks seafood-related happen 
annually in the United States; the majority of those outbreaks are attributed to V. 
parahaemolyticus (26). A single outbreak of V. parahaemolyticus linked to oysters from 
Oyster Bay Harbor in 2012, resulted in 28 cases from nine states. Prior to this outbreak 
the strain responsible had only been found in the Pacific Northwest (27).  Reducing the 
number of infections from V. parahaemolyticus would have a strong effect on the 
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reduction of vibriosis overall. Prevention of foodborne cases should be of primary 
concern. 
 V. vulnificus was the second most common species reported to COVIS since 
1988. V. vulnificus cases are the most severe and result in the highest number of 
hospitalizations and deaths (18, 20). Gulf coast oysters have been attributed to causing 
the majority of foodborne V. vulnificus infections and targeted prevention efforts have 
focused on reducing V. vulnificus in oysters (28). As a result, incidence rates may be less 
dramatic due to the use of post-harvest processing methods to reduce contamination of 
raw oysters in the seafood industry (24, 25). California has seen a significant reduction in 
infections and deaths as a result of restricting the sale of Gulf Coast oysters harvested 
between April 1 and October 31 (24). V. vulnificus cases had the largest number with 
unknown transmission route (n=514, 25.7%), possibly due to inability to correctly 
classify cases based on exposure (e.g., patients ate seafood and swam in the water). 
Therefore, prevention efforts to reduce V. vulnificus cases should be directed towards 
both foodborne and non-foodborne transmission because infections can be severe and 
deadly especially among patients with pre-existing conditions (18).  
  Incidence rates for non-foodborne V. alginolyticus cases have been increasing 
steadily and were 0.04 per 100,000 population in 2011. The majority of infections with V. 
alginolyticus resulted in skin and soft tissue infections, including otitis media (13, 21). 
For states like Florida, the season for water exposures is longer due warmer water and air 
temperatures putting higher numbers of persons at risk for infection (13). Patients were 
on average younger than those with infections from the other three species (21). 
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Consequently, the focus of V. alginolyticus prevention should be towards educating 
persons at risk and parents about water exposures, especially those with existing wounds.   
V. cholerae was the species with the lowest number of cases reported. When 
categorized by transmission, more cases were foodborne (65.9%) and most cases 
presented with gastroenteritis. Previous research has shown that the case fatality rate of 
infection is high (2).  However, it was observed in this thesis that V. cholerae cases had a 
high proportion of hospitalization (45.9%) but few (5.3%) resulted in death. This could 
be due to efforts to reduce contamination in shellfish targeted towards other species that 
also may have had an effect on the reduction of V. cholerae. The seasonality of V. 
cholerae infections differed compared to the other species; notably foodborne cases 
peaked in May. Incidence rates have remained steady. V. cholerae cases can be severe as 
indicated by the high number of hospitalizations prevention efforts should focus on 
reducing foodborne transmitted infections.  
 The information presented in this thesis describes the relationships between 
Vibrio spp., transmission routes, and their role in incidence of vibriosis in the United 
States. The differences in incidence rates by transmission provide a clearer picture of the 
burden of illness.  Most notably, the increasing rates among foodborne V. 
parahaemolyticus and non-foodborne V. alginolyticus cases.  This thesis has also 
confirmed that accurately determining transmission route using specimen site and 
exposure data can be successful when data is available for each patient. Thus, signifying 
the importance for complete case report forms for accurate surveillance.  
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5.2 Study Limitations 
There were several limitations to this thesis related to reporting. As with all 
passive surveillance systems, there is underreporting. Whether this is due to under-
diagnosis or lack of clinical awareness of vibriosis is unknown. Persons with vibriosis 
may or may not seek medical attention. It is likely that only the most severe cases seek 
medical attention. Persons with gastrointestinal symptoms may not have a stool culture 
performed and thus will never be reported. Lack of healthcare provider awareness of the 
clinical presentation of vibriosis also may contribute to under-diagnosis, making the 
number of cases reported a fraction of what is actually occurring. Estimates of illness 
from the CDC corrected data for under-reporting and counts were doubled to account for 
under-diagnosis of infections to address this issue (4).  
Reporting rates for vibriosis have varied over time. In the initial years of 
surveillance, reporting varied by state. Since 2007, when reporting for vibriosis became 
nationally notifiable, it is assumed that states reporting no cases did not have any 
laboratory-confirmed cases.  It is difficult to determine whether some cases are not being 
diagnosed and reported or whether cases are just not occurring in certain states before 
2007. It is also difficult to determine before their first reported cases what the true burden 
of illness was for those states that started reporting later.  It is also possible that there is 
differential diagnostic suspicion by state. For instance, awareness of the impact of 
vibriosis in their population may be greater in coastal states.  
Incomplete data was another limitation to this thesis. The absence of information 
on the case report form can significantly affect data. Forms may be incomplete or patients 
47 
 
lost to follow-up and unavailable for interview. Some data are especially important for 
understanding of vibriosis (e.g., information on pre-existing conditions, where seafood 
was consumed, and location of skin exposure). Incomplete data also made it difficult to 
categorize cases by transmission and contributed to a higher rate of cases with unknown 
transmission. Inability to validate exposure or specimen site categories can lead to 
misclassification of transmission route and is a weakness of the data.  
 
5.4 Conclusion 
Vibriosis is a significant public health problem and reported infections are 
increasing. Outcomes associated with vibriosis are an indicator of importance for 
reducing the burden of illness in the United States.  Transmission routes are central to 
understanding trends in infection and for directing prevention efforts. 
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